The effect of recombinant human soluble thrombomodulin on renal function and mortality in septic disseminated intravascular coagulation patients with acute kidney injury: a retrospective study
Abstract Background Clinical evidence showing the effectiveness of recombinant human soluble thrombomodulin (rhTM) for treating sepsis-induced disseminated intravascular coagulation (DIC) and organ dysfunction (particularly renal injury) is limited because of differences in the inclusion criteria an...
Main Authors: | Masayuki Akatsuka, Yoshiki Masuda, Hiroomi Tatsumi, Tomoko Sonoda |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | Journal of Intensive Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40560-020-00512-w |
Similar Items
-
Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
by: Hayakawa M
Published: (2017-12-01) -
Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2017-11-01) -
Effects of thrombomodulin alfa on hemostatic parameters in disseminated intravascular coagulation: Post hoc analysis of a phase 3 randomized controlled trial
by: Takashi Ito, et al.
Published: (2020-10-01) -
Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
by: Toshiaki Iba, et al.
Published: (2019-05-01) -
Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study
by: Yuki Asai, et al.
Published: (2020-12-01)